Wearable devices (wearables) are a rich source of health-related data that can help accelerate study timelines, reduce participant burden, generate novel insights, and make faster, better-informed clinical decisions based on high-quality, real-world evidence.
The use of wearables in real-world studies has seen significant growth, with analysts predicting that 70% of clinical trials will incorporate wearable devices by 2025. Clinicaltrials.gov reports approximately 1,500 trials currently using wearables, with over 700 completed as of August 2023.
Commercial-grade wearables have the potential to transform clinical trials, enabling efficient and cost-effective remote monitoring. They have been successfully used to monitor wearing-off symptoms in Parkinson’s Disease patients and have shown excellent accuracy compared to gold standards in cardiovascular disease assessment.
But how do you select a wearable, which measurements should you choose, and how do you go about operationalising a study using wearables?
Aparito has gained valuable experience implementing consumer wearables in global studies and understanding both the opportunities and challenges they present.
In this white paper, we share:
- our work utilising commercial-grade wearables in global studies with 3000 patients enrolled across two dozen countries spanning EMEA, AMER and APAC
- the myriad choices one must navigate to select the right wearable device considering factors such as data accuracy, device compatibility, and participant acceptance
- what’s next for wearable devices in clinical trials of the future?